China’s Public Payer Challenged To Support Domestic Innovative Drug Market

But Deficit Too Big?

 
• By Dexter Jie Yan
  
China domestic market
Can China’s public payer prop up the domestic novel drug market? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia